Biography
David Barr is a partner in the firm’s Intellectual Property practice where he co-chairs the Patent Litigation practice. David’s practice focuses on patent litigation, adversarial patent office proceedings, transactions, and counseling for life sciences clients. He has litigated and tried patent cases to both the bench and juries in matters involving small molecules, therapeutic antibodies, cell and gene therapies, diagnostics, and medical devices, including Hatch-Waxman and biologics litigation, and has represented clients in appeals to the Court of Appeals for the Federal Circuit. He frequently coordinates with his clients’ foreign patent counsel when their matters have international scope. David also advises on and litigates trade secret issues for his life sciences clients.
David also has extensive experience in life sciences transactions, including mergers and acquisitions, asset purchases, and licensing and collaboration agreements. He is known for bringing to bear his deep patent litigation experience and knowledge of FDA regulatory issues in analyzing complex life sciences transactions, both in due diligence and in drafting patent license and related agreements.
David has authored numerous articles and is a frequent speaker on intellectual property issues. He is the co-author and co-editor of the Practicing Law Institute’s treatise Pharmaceutical and Biotech Patent Law, and co-chairs PLI’s annual program on Recent Developments in Pharmaceutical and Biotech Patent Law.